Adrenocortical Carcinoma Symptoms: Early Detection and Genetic Insights
At a Glance
- Sample Required: Blood or saliva for genetic testing (if indicated)
- Fasting Rules: No fasting required for genetic tests
- Turnaround Time (TAT): 7–10 business days
- Base Cost: [Insert Current 2026 Price]
Understanding Adrenocortical Carcinoma
Adrenocortical carcinoma (ACC) is a rare and aggressive cancer that arises from the adrenal cortex—the outer layer of the adrenal glands located atop each kidney. These glands produce essential hormones that regulate metabolism, blood pressure, and stress responses. ACC often presents with symptoms related to hormone overproduction or tumor mass effect. Early detection is critical for improving prognosis, as localized tumors are more amenable to surgical resection.
In India, awareness of ACC is low, but advances in diagnostic imaging and molecular testing have enhanced our ability to identify this condition at earlier stages. This article provides a comprehensive overview of ACC symptoms, diagnostic approaches, and the role of genetic testing in hereditary predisposition.
Symptoms and Clinical Presentation
Symptoms of ACC can be subtle and often mimic more common conditions. They are broadly categorized into two types: those caused by hormone excess (functional tumors) and those due to tumor growth (mass effect). The following table summarizes key symptoms and their potential hormonal associations.
| Symptom | Description | Possible Hormonal Cause |
|---|---|---|
| Weight gain or loss | Rapid, unexplained changes in body weight | Cortisol excess (Cushing's syndrome) or androgen excess |
| Muscle weakness | Proximal muscle weakness, especially in thighs and shoulders | Cortisol-induced protein catabolism |
| High blood pressure | Hypertension resistant to standard treatment | Mineralocorticoid excess (aldosterone) or cortisol |
| Skin changes | Darkening of skin (hyperpigmentation), purple striae, easy bruising | ACTH excess or cortisol |
| Increased hair growth (hirsutism) | Facial and body hair growth in women | Androgen excess |
| Headaches | Persistent, often severe headaches | Hypertension or mass effect |
| Abdominal pain or fullness | Pain in the upper abdomen or flank, feeling of fullness | Tumor mass effect |
| Mood changes or anxiety | Depression, irritability, anxiety | Cortisol and catecholamine effects |
If you experience any of these symptoms persistently for more than two weeks, it is essential to consult a healthcare provider. Early evaluation can differentiate ACC from benign adrenal adenomas or other endocrine disorders.
Diagnostic Approaches
Diagnosis of ACC typically involves a combination of imaging studies, hormonal assays, and histopathological confirmation. Imaging modalities such as CT or MRI are used to characterize adrenal masses. Hormonal workup includes measurement of cortisol, androgens, aldosterone, and catecholamines. Definitive diagnosis requires biopsy or surgical pathology.
In cases where hereditary syndromes are suspected, genetic testing plays a pivotal role. DNA Labs India offers comprehensive genomic profiling using Next-Generation Sequencing (NGS) and Whole Exome Sequencing (WES) to identify germline mutations associated with ACC, such as TP53 (Li-Fraumeni syndrome), IGF2, and CTNNB1 alterations.
Genetic Testing and Hereditary Syndromes
Approximately 5–10% of ACC cases are associated with inherited cancer predisposition syndromes. The most common include:
- Li-Fraumeni syndrome – caused by TP53 mutations, increases risk of ACC, sarcomas, and breast cancer.
- Beckwith-Wiedemann syndrome – associated with IGF2 overexpression, leading to pediatric ACC.
- Lynch syndrome – due to mismatch repair gene mutations, also elevates ACC risk.
Genetic testing is recommended for individuals with a family history of these syndromes, early-onset ACC (before age 40), or multiple primary tumors. DNA Labs India's NGS-based panels provide accurate and timely results to guide surveillance and preventive strategies.
Management and Prognosis
Treatment for ACC depends on stage and resectability. Surgical resection with negative margins remains the cornerstone for localized disease. Adjuvant therapy with mitotane is often used to reduce recurrence. For advanced disease, chemotherapy and targeted therapies may be considered. Prognosis is highly variable; early-stage ACC has a 5-year survival rate of 60–80%, while metastatic disease has a poorer outlook.
Regular follow-up with imaging and hormonal markers is essential to detect recurrence early. Genetic counseling is recommended for patients with germline mutations to address family implications.
When to See a Doctor
You should seek medical attention if you experience any combination of the symptoms listed above, especially if they are new, persistent, or worsening. Additionally, if you have a known family history of ACC or related hereditary syndromes, proactive screening is advised. Early consultation can lead to timely diagnosis and better outcomes.
At DNA Labs India, we are committed to providing accurate and reliable genetic testing services. Our laboratory is ISO 9001 certified, ensuring high-quality standards in every test we perform. For more information about our ACC genetic testing panels, please contact us.
Conclusion
Adrenocortical carcinoma is a rare but serious malignancy. Awareness of its symptoms and risk factors is crucial for early detection. Advances in genetic testing have opened new avenues for identifying hereditary predisposition and guiding personalized management. If you have concerns about your adrenal health or genetic risk, do not hesitate to consult a healthcare professional and consider genetic evaluation.

